ARALEZ PHARMACEUTICALS ARALEZ PHARMACEUTICALS ARALEZ PHARMACEUTICALS ARALEZ PHARMACEUTICALS
  • About
      • About Us
    • History
      • Our Company
      • Our Mission
    • Leadership
      • Board of Directors
      • Management
    • We Care
      • Environmental Commitment
  • Portfolio
      • Portfolio
    • Cardio Health
      • Bezalip SR
      • Fibricor
      • Toprol-XL
      • Viskazide
      • Visken
      • Yosprala
      • Zontivity
    • Pain Management
      • Cambia
      • Durela
      • Fiorinal
      • Fiorinal C
      • MT400
      • NeoVisc
      • Treximet
      • Uracyst
      • Vimovo
    • Other Products
      • Blexten
      • CollatampG
      • MoviPrep
      • Mutaflor
      • Normacol
    •  
      • PegaLAX
      • Proferrin
      • Purfem
      • Resultz
      • Soriatane
  • Investors
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Investment Calculator
      • Stock Dividends/Basis
      • Analyst Coverage
    • News Releases
      • News Releases
    • Presentations & Webcasts
      • Upcoming Events
      • Past Events
      • Presentations
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Annual Reports & Proxies
    • Shareholder Resources
      • Email Alerts
      • FAQ
      • IR Contact Information
    • Corporate Governance
      • Overview
      • Committee Composition
      • Charters/Policies
      • Sunshine Act
  • News
      • News
    • Aralez Pharmaceuticals
      • Archive News
      • Historical Presentations
    • Pozen
      • Archive News
      • Historical Filings
      • Historical Presentations
    • Tribute Pharmaceuticals
      • Archive News
      • Historical Filings
      • Historical Presentations
  • Careers
      • Careers
    • More Information
      • Working at Aralez
      • Recruiting Agencies
  • Contact Us
      • Contact Us
    • Global Headquarters
      • 7100 West Credit Avenue
        Suite 101
        Mississauga, Ontario L5N 0E4
        905-876-1118

        Fax: 905-567-4618
    • Ireland Headquarters
      • 2 Hume Street
        Dublin 2, DO2 FT82, Ireland
        +353-1-9038470

        Fax: +353-1-9038468
    • U.S. Headquarters
      • 400 Alexander Park Drive
        Princeton, NJ 08540
        609-917-9330
        Toll Free: 866-294-9840

        Fax: 609-201-2790
        Toll Free Fax: 866-295-4610
  • Français
ARALEZ PHARMACEUTICALS ARALEZ PHARMACEUTICALS
  • About
    • History
      • Our Mission
    • Leadership
      • Management
  • Portfolio
    • Cardiovascular
      • Bezalip SR
      • Fibricor
      • Viskazide
      • Visken
      • YOSPRALA
      • Zontivity
      • Toprol-XL
    • Pain
      • Cambia
      • Durela
      • Fiorinal
      • Fiorinal C
      • MT400
      • NeoVisc
      • Treximet
      • Uracyst
      • Vimovo
    • Other Specialties
      • Blexten™
      • CollatampG
      • MoviPrep
      • Mutaflor
      • Normacol
      • PegaLAX
      • Proferrin
      • Purfem
      • Resultz
      • Soriatane
  • Investors
    • Stock Information
  • News
    • Aralez Pharmaceuticals
      • Archive News
      • Historical Presentations
    • Pozen Pharmaceuticals
      • Archive News
      • Historical Filings
      • Historical Presentations
    • Tribute Pharmaceuticals
      • Archive News
      • Historical Filings
      • Historical Presentations
  • Careers
    • External Recruiting Agencies
  • Contact Us
  • family
    Learn More
  • lab
    Learn More About Our Portfolio
  • hands
    Investors
    Get more information on how you can grow with us.
    Investors Information
  • heart
    Cardiovascular
    View Our Portfolio Page in this Therapeutic Category.
    Learn More

About Aralez

The combination of POZEN and Tribute Pharmaceuticals represents an important strategic transformation that created Aralez Pharmaceuticals, a specialty pharmaceutical company with a compelling growth platform.

Our Portfolio

The Aralez portfolio of approved products is anchored in cardiovascular disease and plans for continued development and growth in this and other specialty areas.

For Investors

Aralez is focused on delivering meaningful products to improve patients’ lives while growing shareholder value in short, medium and long-term. Investor information such as press releases, presentations and webcasts can be found in this section.

Cardiovascular Health
   Cardiovascular Health
Pain Management
Pain Management
Other Products
Other Products
Portfolio
Products Portfolio

About Aralez

The combination of POZEN Inc. and Tribute Pharmaceuticals represents an important strategic transformation, creating Aralez Pharmaceuticals, a specialty pharmaceutical company with a compelling growth platform.

RSS Press Releases

  • Aralez Announces Fourth Quarter and Full-Year 2017 Financial Results
  • Aralez To Announce Fourth Quarter And Full-Year 2017 Results On March 13, 2018
  • Aralez to Present at the 2018 BIO CEO and Investor Conference

Site Map

Home
About
Portfolio
Investors
News
Careers
Contact Us

Contact Info

Email: [email protected]
Sign up for news alerts
Legal Notice
Privacy Policy

© 2018 Aralez Pharmaceuticals Inc.
Hosted and managed by Body1

The website you are visiting is for Canadian patients only.

Proceed  Stay Here

The website you are visiting is for Canadian patients only.

Proceed  Stay Here

The website you are visiting is for Canadian patients only.

Proceed  Stay Here

The website you are visiting is for Canadian patients only.

Proceed  Stay Here

The website you are visiting is for Canadian patients only.

Proceed  Stay Here